Published February 3, 2023
| Version 1
Project milestone
Open
NIH Contribution to phased clinical development of drugs approved from 2010-2019: Tech Note
Description
Short Background:
This report describes the methods and preliminary results for the manuscript titled, “Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry.”
Files
Tech Note 2023-1 NIH contribution to phased clinical development of drugs approved 2010-2019 2023-01-26.pdf
Files
(498.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:124e05234a6add600586eead7bb45f61
|
498.0 kB | Preview Download |